Novartis obtains cancellation of GSK’s trademark on ground of non-use

Colombia

In a victory for multinational pharmaceutical company Novartis AG, the Colombian Trademark Office has ordered the cancellation of a trademark owned by GlaxoSmithKline, finding that it had not been used in the relevant class.

Unlock unlimited access to all WTR content